Zhongzhi Pharmaceutical Holdings Limited (3737.HK)
HKD 0.91
(0.0%)
HKD 0.91
(0.0%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 2.04 Billion | 1.82 Billion | 1.74 Billion | 1.6 Billion | 1.34 Billion | 1.14 Billion |
| Cost of Revenue | 831.66 Million | 758.58 Million | 685.15 Million | 612.78 Million | 507.94 Million | 438.72 Million |
| Gross Profit | 1.21 Billion | 1.06 Billion | 1.06 Billion | 991.08 Million | 834.23 Million | 703.42 Million |
| Operating Expenses | 1.01 Billion | 934.13 Million | 996.67 Million | 828.72 Million | 682.56 Million | 611.29 Million |
| Selling, General and Administrative Expenses | 994.8 Million | 914.56 Million | 932.13 Million | 790.57 Million | 647.75 Million | 570.58 Million |
| Research and Development Expenses | 49.98 Million | 46.35 Million | 43.83 Million | 50.18 Million | 47.44 Million | 52.46 Million |
| Other Expenses | - | 5.7 Million | 2.48 Million | -4.23 Million | 2000.00 | 1.55 Million |
| Cost and Expenses | 1.85 Billion | 1.69 Billion | 1.68 Billion | 1.44 Billion | 1.19 Billion | 1.05 Billion |
| Operating Income | 198.88 Million | 103.5 Million | 79.57 Million | 141.11 Million | 136.76 Million | 78.2 Million |
| Interest Expense | 7.86 Million | 6.55 Million | 7.08 Million | 5.21 Million | 4 Million | 239 Thousand |
| Income Tax Expense | 43.44 Million | 23.73 Million | 9.44 Million | 28.6 Million | 41.24 Million | 16.75 Million |
| Earnings before Tax | 207.58 Million | 130.65 Million | 61.81 Million | 167.22 Million | 155.94 Million | 101.82 Million |
| Net Income | 162.77 Million | 106.38 Million | 52.12 Million | 138.53 Million | 114.69 Million | 85.06 Million |
| Earnings Per Share Basic | 0.19 | 0.13 | 0.06 | 0.17 | 0.14 | 0.10 |
| Earnings Per Share Diluted | 0.19 | 0.13 | 0.06 | 0.17 | 0.14 | 0.10 |
| Weighted Average Shares Outstanding | 856.71 Million | 846.99 Million | 836.95 Million | 828.79 Million | 833.34 Million | 833.22 Million |
| Weighted Average Shares Outstanding (Diluted) | 846.99 Million | 846.99 Million | 836.95 Million | 828.79 Million | 834.54 Million | 833.22 Million |
| Gross Margin | 0.59 | 0.58 | 0.61 | 0.62 | 0.62 | 0.62 |
| EBIT Margin | 0.15 | 0.08 | 0.07 | 0.13 | 0.12 | 0.09 |
| Profit Margin | 0.08 | 0.06 | 0.03 | 0.09 | 0.09 | 0.07 |
| EBITDA | 317.52 Million | 153.87 Million | 119.71 Million | 203.69 Million | 166.49 Million | 102.44 Million |
| Earnings Before Tax Margin | 0.10 | 0.06 | 0.05 | 0.09 | 0.10 | 0.07 |
| Breakdown | 2024 Q2 | 2023 Q4 | 2023 FY | 2023 Q2 | 2022 FY | 2022 Q4 |
|---|---|---|---|---|---|---|
| Revenue | 1.08 Billion | 955.48 Million | 2.04 Billion | 1.09 Billion | 1.82 Billion | 979.53 Million |
| Cost of Revenue | 461.38 Million | 415.84 Million | 831.66 Million | 419.36 Million | 758.58 Million | 417.37 Million |
| Gross Profit | 627.04 Million | 539.64 Million | 1.21 Billion | 674.96 Million | 1.06 Billion | 562.16 Million |
| Operating Expenses | 524 Million | 525.56 Million | 1.01 Billion | 507.13 Million | 934.13 Million | 525.39 Million |
| Selling, General and Administrative Expenses | 501.12 Million | 496.13 Million | - | 498.67 Million | - | 515.37 Million |
| Research and Development Expenses | 22.88 Million | 29.43 Million | - | 20.55 Million | - | 28.36 Million |
| Other Expenses | - | - | 9.24 Million | - | 5.7 Million | - |
| Cost and Expenses | 985.38 Million | 941.4 Million | 1.85 Billion | 926.49 Million | 1.69 Billion | 942.77 Million |
| Operating Income | 103.04 Million | 14.07 Million | 163.92 Million | 147.6 Million | 103.5 Million | 16.57 Million |
| Interest Expense | - | - | 7.86 Million | - | 6.55 Million | - |
| Income Tax Expense | 20.76 Million | 11.78 Million | 43.44 Million | 31.66 Million | 23.73 Million | 5.86 Million |
| Earnings before Tax | 105.01 Million | 39.76 Million | 207.58 Million | 167.81 Million | 130.65 Million | 35.23 Million |
| Net Income | 83.44 Million | 27.87 Million | 162.77 Million | 134.9 Million | 106.38 Million | 29.33 Million |
| Earnings Per Share Basic | 0.10 | 0.03 | - | 0.16 | - | 0.03 |
| Earnings Per Share Diluted | 0.10 | 0.03 | - | 0.16 | - | 0.03 |
| Weighted Average Shares Outstanding | 846.84 Million | 899.22 Million | 856.71 Million | 848.42 Million | 846.99 Million | 847.01 Million |
| Weighted Average Shares Outstanding (Diluted) | 846.83 Million | 846.99 Million | 846.99 Million | 846.99 Million | 846.99 Million | 846.99 Million |
| Gross Margin | 0.58 | 0.56 | 0.59 | 0.62 | 0.58 | 0.57 |
| EBIT Margin | 0.11 | 0.04 | - | 0.16 | - | 0.04 |
| Profit Margin | 0.08 | 0.03 | 0.08 | 0.12 | 0.06 | 0.03 |
| EBITDA | 117.92 Million | 39.35 Million | - | 175.46 Million | - | 42.5 Million |
| Earnings Before Tax Margin | 0.09 | 0.01 | 0.08 | 0.13 | 0.06 | 0.02 |
TEP
PSMMY
300497
6151
GRAND
AVON